NYSE · SERVICES-HEALTH SERVICES · LARGE CAP
U S Physical Therapy Inc. /NV USPH
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY5 YEARS OF DIVIDEND GROWTH
Revenue · FY2025
$781.0M
▲ 16.3% vs FY2024
Dividend streak
5 yrs
Raised every year since 2021
EPS · FY25
$1.42
Dividend / sh · FY25
$1.80
Payout · FY25
69%
ROE · FY25
8.2%
Net margin · FY25
5.1%
Dividend coverage
0.8×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 781.0M
Revenue, FY2025 · full 17-year series below
Revenue
Net income
5 cents of every revenue dollar became profit this year.
Per share
USD 1.42
Diluted EPS, FY2025
EPS
Dividend
Earnings covered only a fraction of the dividend — the rest came from cash or borrowing.
Profitability
8.2%
Return on equity, FY2025
ROE
Operating margin11.1%
Net margin5.1%
Return on assets3.3%
Each USD of equity produced 8 cents of profit this year.
Returned to shareholders
USD 32.9M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 27.4M
Net buybacksUSD 5.6M
Share of profit83.2%
Consecutive raises5 years
USD 27.4M in dividends and USD 5.6M in buybacks — 83% of the year's profit went back to shareholders.
Growth
+13.0% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+12.2%
+13.0%
+9.0%
+9.1%
Net income
+7.2%
+2.4%
+6.7%
+6.4%
EPS, diluted
−14.2%
−10.6%
−1.5%
+0.5%
Dividend / share
+3.2%
+41.3%
+11.6%
Returned to shareholders
+15.6%
+51.6%
+16.0%
+26.4%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 1.2B
total assets, end of FY2025
Total assetsUSD 1.2B
EquityUSD 476.4M
CashUSD 35.6M
Gross debtUSD 162.5M
Net debtUSD 126.9M
Current ratio1.01×
Net debt stands at 27% of equity.
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
0.8
0.7
0.6
0.6
0.5
0.4
0.5
0.5
0.4
0.4
0.3
0.3
0.3
0.2
0.2
0.2
0.2
Operating income $B
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
EBITDA $B
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
EPS, diluted $
1.42
1.84
1.28
2.25
2.41
2.48
2.45
1.31
1.76
1.64
1.66
1.57
1.05
1.51
1.75
1.32
1.00
Dividend / sh $
1.80
1.76
1.72
1.64
1.46
0.32
1.14
0.92
0.80
0.68
0.60
0.48
0.40
0.76
0.32
·
·
Payout %
69
84
85
66
46
12
36
33
45
41
36
31
38
50
18
·
·
ROE %
8.2
6.5
7.1
10.5
14.3
13.6
17.6
16.6
11.3
11.5
13.0
13.9
10.4
16.0
19.9
15.0
·
Shares out B
·
·
·
·
·
·
·
0.01
0.01
·
·
·
·
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
41 of 49
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 5 failures and 3 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed